» Articles » PMID: 18353358

Recycle or Die: the Role of Autophagy in Cardioprotection

Overview
Date 2008 Mar 21
PMID 18353358
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy is a highly conserved cellular process responsible for the degradation of long-lived proteins and organelles. Autophagy occurs at low levels under normal conditions, but is upregulated in response to stress such as nutrient deprivation, hypoxia, mitochondrial dysfunction, and infection. Upregulation of autophagy may be beneficial to the cell by recycling of proteins to generate free amino acids and fatty acids needed to maintain energy production, by removing damaged organelles, and by preventing accumulation of protein aggregates. In contrast, there is evidence that enhanced autophagy can contribute to cell death, possibly through excessive self-digestion. In the heart, autophagy has an essential role for maintaining cellular homeostasis under normal conditions and increased autophagy can be seen in conditions of starvation, ischemia/reperfusion, and heart failure. However, the functional significance of autophagy in heart disease is unclear and controversial. Here, we review the literature and discuss the evidence that autophagy can have both beneficial and detrimental roles in the myocardium depending on the level of autophagy, and discuss potential mechanisms by which autophagy provides protection in cells.

Citing Articles

From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.

Gharib E, Robichaud G Int J Mol Sci. 2024; 25(17).

PMID: 39273409 PMC: 11395697. DOI: 10.3390/ijms25179463.


Inhibition of MEG3 ameliorates cardiomyocyte apoptosis and autophagy by regulating the expression of miRNA-129-5p in a mouse model of heart failure.

Mi S, Huang F, Jiao M, Qian Z, Han M, Miao Z Redox Rep. 2023; 28(1):2224607.

PMID: 37338021 PMC: 10286679. DOI: 10.1080/13510002.2023.2224607.


The beneficial role of exercise in preventing doxorubicin-induced cardiotoxicity.

Gaytan S, Lawan A, Chang J, Nurunnabi M, Bajpeyi S, Boyle J Front Physiol. 2023; 14:1133423.

PMID: 36969584 PMC: 10033603. DOI: 10.3389/fphys.2023.1133423.


Mining of Potential Biomarkers and Pathway in Valvular Atrial Fibrillation (VAF) via Systematic Screening of Gene Coexpression Network.

Zou F, Chen T, Xiang X, Peng C, Huang S, Ma S Comput Math Methods Med. 2022; 2022:3645402.

PMID: 36226239 PMC: 9550484. DOI: 10.1155/2022/3645402.


Protein Quality Control at the Sarcomere: Titin Protection and Turnover and Implications for Disease Development.

Kotter S, Kruger M Front Physiol. 2022; 13:914296.

PMID: 35846001 PMC: 9281568. DOI: 10.3389/fphys.2022.914296.


References
1.
Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V . Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003; 107(7):984-91. DOI: 10.1161/01.cir.0000051865.66123.b7. View

2.
Khan S, Salloum F, Das A, Xi L, Vetrovec G, Kukreja R . Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. J Mol Cell Cardiol. 2006; 41(2):256-64. DOI: 10.1016/j.yjmcc.2006.04.014. View

3.
Boyd J, Gallo G, Elangovan B, Houghton A, Malstrom S, Avery B . Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene. 1995; 11(9):1921-8. View

4.
McMullen J, Sherwood M, Tarnavski O, Zhang L, Dorfman A, Shioi T . Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation. 2004; 109(24):3050-5. DOI: 10.1161/01.CIR.0000130641.08705.45. View

5.
Xu Y, Kim S, Li Y, Han J . Autophagy contributes to caspase-independent macrophage cell death. J Biol Chem. 2006; 281(28):19179-87. DOI: 10.1074/jbc.M513377200. View